The document contains the transcript of the Q2 and H1 FY27 Earnings Conference Call for QMS Medical Allied Services Limited, held on November 17, 2026.
The event was an earnings call to discuss operating and financial highlights for the quarter and half year ended September 30, 2026.
Management participants included Mr. Mahesh Makhija (Chairman and Managing Director) and Mr. Mohit Tamhankar (Director, Compliance).
The transcript was made available on the company's website at https://qmsmas.com/ and filed with the stock exchange on November 21, 2026, signed by Company Secretary and Compliance Officer Toral Jailesh Bhadra.
Financial Highlights Disclosed:
Q2 FY27 Revenue from Operations: INR 52.5 crores (up 17.5% YoY from INR 44.7 crores in Q2 FY26)
H1 FY27 Revenue from Operations: INR 109.4 crores (up 20% YoY from INR 91.2 crores in H1 FY26)
Q2 FY27 EBITDA: INR 6.5 crores (EBITDA margin 12.4%) compared to INR 6.9 crores in Q2 FY26
H1 FY27 EBITDA: INR 14.8 crores (up 11% YoY from INR 13.4 crores in H1 FY26) with EBITDA margin of 13.6%
Q2 FY27 PAT: INR 2.4 crores (PAT margin 4.6%) compared to INR 3.6 crores in Q2 FY26
H1 FY27 PAT: INR 6.4 crores (PAT margin 5.8%) compared to INR 6.7 crores in H1 FY26
Employee expenses increased to INR 12.6 crores in Q2 FY27 from INR 3 crores in Q2 FY26 due to expansion investments
Strategic Business Updates:
The company is pursuing a two-vertical strategy: QMS Services (patient support programs) and QMS Products (medical device distribution and manufacturing)
Completed acquisition of remaining 24% stake in Saarathi Healthcare in September 2026, making it a wholly owned subsidiary
Announced composite scheme of arrangement to merge HCAH's patient support program business with Saarathi Healthcare through all-share swap (approximately 1.32 crore shares to be issued)
The combined service business is envisaged to be separately listed on NSE, subject to regulatory approvals
Combined platform will have 160+ active patient support programs, impacted 1.2+ million patients, and 2,000+ healthcare professionals across 35+ cities
Combined service business reported revenue of ~INR 109 crores in FY26 with target of ~INR 180 crores for FY27
Signed 5-year exclusive agreement with HEINE Opto for marketing and distribution of primary diagnostic instruments in India from January 1, 2027
HEINE generated approximately INR 30 crores revenue from India in 2026
Signed binding MOU to acquire 100% of BeamOptics Scientific, a technology company specializing in optical systems and IVD instruments with 7 patents filed